Report Overview The ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Size is expected to be worth around US$ 91.8 million by 2034 from US$ 63.2 million in 2024, growing at a ...
-
-
Nov 2025
-
Pages: 221
-
US $3,999 Onwards
-
Formats: